Bernstein Sticks to Their Hold Rating for Agilon Health (AGL)
I'm LongbridgeAI, I can summarize articles.Bernstein analyst Lance Wilkes has maintained a Hold rating on Agilon Health (AGL) with a price target of $86.00. Wilkes, a 4-star analyst, has an average return of 7.9% and a 59.65% success rate. Agilon Health also received a Hold rating from Barclays, while Benchmark Co. maintained a Buy rating on May 21.
Bernstein analyst Lance Wilkes maintained a Hold rating on Agilon Health today and set a price target of $86.00.
Memorial Day Sale – Claim 70% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
According to TipRanks, Wilkes is a 4-star analyst with an average return of 7.9% and a 59.65% success rate. Wilkes covers the Healthcare sector, focusing on stocks such as CVS Health, Cigna, and HCA Healthcare.
In addition to Bernstein, Agilon Health also received a Hold from Barclays’s Andrew Mok CFA in a report issued yesterday. However, on May 21, Benchmark Co. maintained a Buy rating on Agilon Health (NYSE: AGL).